Skip to main content
. 2020 Nov 11;7:608259. doi: 10.3389/fmed.2020.608259

Table 2.

Clinical features, disease classification of patients with COVID-19 with and without GI symptoms.

All patient (n = 1077) Patients with GI symptoms (n = 359) Patients without GI symptoms (n = 718) p-value
GI symptoms
   Abdominal pain 38 (3.5) 38 (10.6) 0 (0)
   Acid reflux 12 (1.1) 12 (3.3) 0 (0)
   Nausea or vomiting 71 (6.6) 71 (19.8) 0 (0)
   Abdominal distension 38 (3.5) 38 (10.6) 0 (0)
   Diarrhea 208 (19.3) 208 (57.9) 0 (0)
   Tenesmus 9 (0.8) 9 (2.5) 0 (0)
   Belching 6 (0.6) 6 (1.7) 0 (0)
Other symptoms
   Fever 777 (72.1) 287 (79.9) 490 (68.2) <0.001
   Cough 267 (24.8) 168 (46.8) 99 (13.8) <0.001
   Chest tightness 143 (13.3) 60 (16.7) 83 (11.6) 0.019
   Chest pain 20 (1.9) 6 (1.7) 14 (1.9) 0.816
   Dyspnoea 105 (9.7) 52 (14.5) 53 (7.4) <0.001
   Myalgia 61 (5.7) 31 (8.6) 30 (4.2) 0.003
   Headache 28 (2.6) 12 (3.3) 16 (2.2) 0.311
   Fatigue 240 (22.3) 103 (28.7) 137 (19.1) <0.001
Time of onset of GI symptoms
   On initial presentation 107 (9.9) 107 (29.8) 0 (0)
   During hospitalization 252 (23.4) 252 (70.2) 0 (0)
Disease classification <0.001*
   Mild 29 (2.7) 2 (0.5) 27 (3.8)
   Moderate 485 (45.0) 118 (32.9) 367 (51.1)
   Severe 502 (46.6) 212 (59.1) 290 (40.4)
   Critical 61 (5.7) 27 (7.5) 34 (4.7)

Data are median (IQR) or n (%). p-values were calculated using Mann-Whitney U-test, χ2-test, or Fisher's exact-test, as appropriate. GI, gastrointestinal.

*

χ2-test comparing all subcategories.